elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54256137-17A9B871-28FD-4583-BD3F-6A998BACB173
Q54256137-17A9B871-28FD-4583-BD3F-6A998BACB173
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54256137-17A9B871-28FD-4583-BD3F-6A998BACB173
Predicting Molecular Targets for Small-Molecule Drugs with a Ligand-Based Interaction Fingerprint Approach.
P2860
Q54256137-17A9B871-28FD-4583-BD3F-6A998BACB173
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54256137-17A9B871-28FD-4583-BD3F-6A998BACB173
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5063255088b623a998148342708a7b2f630317e8
P2860
Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.